Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03340311 · ClinicalTrials.gov registry record · NA
Evaluating the Feasibility of Using M-Health to Improve Serum Glucose Logs
A NA study of Gestational Diabetes Mellitus, sponsored by Leslie Balcazar De Martinez.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT03340311: Completed NA study of Gestational Diabetes Mellitus, sponsored by Leslie Balcazar De Martinez.
NCT03340311 is a NA study of Gestational Diabetes Mellitus that has completed, run by Leslie Balcazar De Martinez. The registered enrollment target is 8 participants, below the 418-participant average among 16 other Gestational Diabetes Mellitus trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03340311, a NA study of Gestational Diabetes Mellitus, has completed, sponsored by Leslie Balcazar De Martinez.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Gestational diabetes mellitus (GDM) can cause adverse outcomes for the mother and fetus due to hyperglycemia. The purpose of this study is to evaluate the feasibility of improving pregnant women's glucose logs using a Bluetooth enabled glucose monitor and associated mobile health application and to assess their satisfaction with using mobile health technology.
Primary Outcome
Glucose log completeness will be calculated using the total number of entries required for the period between visits divided by the number of actual entries. For example, if the participant has had 14 days between appointments, 56 entries would be expected, if the patient only records 40 results the completeness score would be 0.71.
Conditions Studied
Interventions
- DEVICE iHealth Wireless Smart Gluco- Monitoring System (BG5)
Study Locations (1)
Virginia
- University of Virginia Maternal Fetal Medicine Clinic - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2018-04-28 |
| Phase | NA |
What the finished NCT03340311 record still lists
NCT03340311 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 418-participant average among 16 other Gestational Diabetes Mellitus trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Gestational Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which iHealth Wireless Smart Gluco- Monitoring System (BG5) is the first listed.
NCT03340311 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03340311 about?
NCT03340311 is a clinical study titled "Evaluating the Feasibility of Using M-Health to Improve Serum Glucose Logs". Gestational diabetes mellitus (GDM) can cause adverse outcomes for the mother and fetus due to hyperglycemia. The purpose of this study is to evaluate the feasibility of improving pregnant women's glucose logs using a Bluetooth enabled glucose monitor and associated mobile health application and to ...
What is the current status of trial NCT03340311?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2017-11-01. Estimated completion is 2018-04-28.
What conditions does trial NCT03340311 study?
This clinical trial studies the following conditions: Gestational Diabetes Mellitus.
What interventions are being tested in trial NCT03340311?
The interventions under investigation include: iHealth Wireless Smart Gluco- Monitoring System (BG5) (DEVICE).
Who is sponsoring clinical trial NCT03340311?
This trial is sponsored by Leslie Balcazar De Martinez, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03340311 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03340311's enrollment target sits among peer trials
8 17th of 16 the lowest of 16 other Gestational Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gestational Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial
RECRUITING · NA
-
A Shared Decision Making Intervention for Diabetes Prevention in Women With a History of Gestational Diabetes Mellitus
ACTIVE NOT RECRUITING · NA
-
Assessing the Effectiveness of a Weight Watchers-based Lifestyle Intervention for the Primary Prevention of Type 2 Diabetes
COMPLETED · NA
-
Supporting American Indian/Alaska Native Mothers and Daughters in Reducing Gestational Diabetes Risk
COMPLETED · NA
-
Intrapartum Glycemic Control With Insulin Infusion Versus Rotating Fluids
COMPLETED · NA
-
Balance After Baby Intervention for Women With Recent Gestational Diabetes
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI